CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Long-Lasting Antiandrogen Withdrawal Syndrome in Castration-Resistant Prostate Cancer: Three Cases With Complete Response

Sang Jin Kim, Jae Hyun Ryu, Yun Beom Kim, Tae Young Jung

Korean J Urol Oncol. 2018;16(1):38-41. Published online 2018 April 27 DOI: https://doi.org/10.22465/kjuo.2018.16.1.38

Long-Lasting Antiandrogen Withdrawal Syndrome in Castration-Resistant Prostate Cancer: Three Cases With Complete Response

Sang Jin Kim, Jae Hyun Ryu, Yun Beom Kim, Tae Young Jung

The Korean Journal of Urological Oncology. 2018;16(1):38-41

Link1

Link2 Link3

Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer

Austin Poole, David Gill, Andrew W. Hahn, Eric Johnson, Emma Carroll, Kenneth Boucher, Roberto Nussenzveig, Benjamin Maughan, Neeraj Agarwal

Clinical Genitourinary Cancer. 2018;16(1):e169-e172

Link1 Link2

Near Complete Response to 177Lu-PSMA-DKFZ-617 Therapy in a Patient with Metastatic Castration Resistant Prostate Cancer

Yadav MP

Journal of Radiology and Oncology. 2017;1(3):083-086

Link1

Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer: Two case reports

KAZUMI NOGUCHI, JUN-ICHI TERANISHI, HIROJI UEMURA, NAOYA FUJIKAWA, KAZUO SAITO, TETSUO MURAI

International Journal of Urology. 2006;13(9):1259-1261

Link1 Link2

Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: A single-center experience

Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara

International Journal of Urology. 2010;17(11):950-955

Link1 Link2

Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide

Masaki Shiota, Asako Machidori, Tatsuro Abe, Keisuke Monji, Eiji Kashiwagi, Ario Takeuchi, Ryosuke Takahashi, Junichi Inokuchi, Akira Yokomizo, Seiji Naito, Masatoshi Eto

International Journal of Urology. 2020;27(12):1109-1115

Link1 Link2 Link3

Durable Complete Remission From Castration-Resistant Prostate Cancer With Sipuleucel-T After Estrogen Withdrawal

Tanya B. Dorff, Cy Wilkins, Mehmet Hepgur, David I. Quinn

Clinical Genitourinary Cancer. 2014;12(2):e55-e58

Link1 Link2

Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate

Koichiro Akakura, Susumu Akimoto, Takemasa Ohki, Jun Shimazaki

Urology. 1995;45(4):700-705

Link1 Link2

Should We Try Antiandrogen Withdrawal in Castration-Resistant Prostate Cancer Patients? Insights From a Retrospective Study

Hiroshi Hongo, Takeo Kosaka, Ryuichi Mizuno, Taisuke Ezaki, Kazuhiro Matsumoto, Shinya Morita, Kazunobu Shinoda, Toshiaki Shinojima, Eiji Kikuchi, Akira Miyajima, Mototsugu Oya

Clinical Genitourinary Cancer. 2016;14(6):e569-e573

Link1 Link2

Dramatic Prostate Specific Antigen Decrease in Response to Discontinuation of Megestrol Acetate in Advanced Prostate Cancer

Nancy A. Dawson, David G. McLeod

The Journal of Urology. 1995;1946-1947

Link1